MetaADEDB 2.0 @ LMMD
Ganciclovir
(JJICLMJFIKGAAU-UHFFFAOYSA-M)
Structure
SMILES
OCC(OCn1cnc2c1nc(N)nc2[O-])CO.[Na+]
Molecular Formula:
C9H12N5NaO4
Molecular Weight:
277.212
Log P:
-0.5392
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
3
TPSA:
142.37
CAS Number(s):
84245-13-6; 107910-75-8
Synonym(s)
1.
Ganciclovir
2.
BIOLF-62
3.
BW-759
4.
Cytovene
5.
Ganciclovir Sodium
6.
Ganciclovir, Monosodium Salt
7.
Gancyclovir
8.
RS-21592
External Link(s)
MeSHD015774
PubChem Compound23707495
23700083
CHEMBLCHEMBL1200850
KEGGdr:D04301
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NeutropeniaFAERS: 5US FAERS
2Accidental exposure to productFAERS: 2US FAERS
3Drug resistanceFAERS: 2US FAERS
4ExtravasationFAERS: 2US FAERS
5Neutrophil morphology abnormalFAERS: 2US FAERS
6Occupational exposure to productFAERS: 2US FAERS
7Accidental exposureFAERS: 1US FAERS
8AgitationFAERS: 1US FAERS
9Bacterial sepsisFAERS: 1US FAERS
10BronchiolitisFAERS: 1US FAERS
11Burning sensationFAERS: 1US FAERS
12Catheter site infectionFAERS: 1US FAERS
13Cerebellar AtaxiaFAERS: 1US FAERS
14Congenital rubella infectionFAERS: 1US FAERS
15CryingFAERS: 1US FAERS
16Cytomegalovirus chorioretinitisFAERS: 1US FAERS
17Cytomegalovirus test positiveFAERS: 1US FAERS
18DeliriumFAERS: 1US FAERS
19Depressed Level of ConsciousnessFAERS: 1US FAERS
20Drug administration errorFAERS: 1US FAERS
21Drug exposure during pregnancyFAERS: 1US FAERS
22Drug ineffectiveFAERS: 1US FAERS
23Extra dose administeredFAERS: 1US FAERS
24HepatitisFAERS: 1US FAERS
25Incorrect dose administeredFAERS: 1US FAERS
26Injection Site ReactionFAERS: 1US FAERS
27Neutropenic infectionFAERS: 1US FAERS
28Neutrophil Pelger-Huet anomaly presentFAERS: 1US FAERS
29Neutrophil count decreasedFAERS: 1US FAERS
30No adverse eventFAERS: 1US FAERS
31Optic AtrophyFAERS: 1US FAERS
32PneumoniaFAERS: 1US FAERS
33PneumonitisFAERS: 1US FAERS
34Product contaminationFAERS: 1US FAERS
35Retinal Artery OcclusionFAERS: 1US FAERS
36Retinal infarctionFAERS: 1US FAERS
37SepsisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
38Throat irritationFAERS: 1US FAERS
39ThrombocytopeniaFAERS: 1US FAERS
40TuberculosisFAERS: 1US FAERS
41Unevaluable eventFAERS: 1US FAERS
42Weight decreasedFAERS: 1US FAERS
43White blood cell count decreasedFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
44treatment failureFAERS: 1US FAERS
45OverdoseCanada Vigilance: 2Canada Vigilance
46ShockCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.